[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337046-105":59,"doc-detail-337046-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pink1-mediated-mitochondrial-activity-confers-olaparib-resistance-in-prostate-cancer-cells","PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells","","Olaparib, a PARP inhibitor used for castration-resistant prostate cancer, faces persistent resistance that limits long-term effectiveness. This study examines how mitochondrial alterations and the PTEN-induced kinase 1 (PINK1) gene contribute to olaparib resistance in castration-resistant prostate cancer cells. RNA sequencing and gene set enrichment analysis reveal increased mitochondrial activity and oxidative phosphorylation in resistant derivatives. Resistant cells show higher respiration, ATP production, spare respiratory capacity, greater mitochondrial mass, and complex I activity. PINK1 overexpression correlates with resistance and poor outcomes, and PINK1 inhibition reduces mitochondrial function, mass, growth, and resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pink1-mediated-mitochondrial-activity-confers-olaparib-resistance-in-prostate-cancer-cells/337046/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pink1-mediated-mitochondrial-activity-confers-olaparib-resistance-in-prostate-cancer-cells/337046.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological focus of this study?","Question",{"text":112,"@type":113},"The study focuses on how mitochondrial alterations and the PINK1 gene contribute to olaparib resistance in castration-resistant prostate cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was mitochondrial activity assessed in olaparib-resistant versus treatment-naive cells?",{"text":117,"@type":113},"It used transcriptomic comparisons with RNA sequencing and gene set enrichment analysis, followed by functional measurements of respiration, ATP production, and related mitochondrial parameters.",{"name":119,"@type":110,"acceptedAnswer":120},"What effect does inhibiting PINK1 have on resistant prostate cancer cells?",{"text":121,"@type":113},"Inhibiting PINK1 expression reduces mitochondrial function and mass, impairs cell growth, and decreases olaparib resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337046,1790258832,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-24-0339](https://doi.org/10.1158/2767-9764.CRC-24-0339)  OPEN ACCESS  \nPINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells  \nZachary A. Schaaf1, Shu Ning1, Amy R. Leslie1, Masuda Sharifi1, Richard Y. Gao2, James P. Maine1, Wei Lou1, Alan P. Lombard1,3,4, Chengfei Liu1,4, Ai-Ming Yu3,4, Nicholas Mitsiades2,4, and Allen C. Gao1,4,5  \n􀀶  \nABSTRACT  \nOlaparib, a PARP inhibitor, is a targeted therapy used in treating various cancers, including castration-resistant prostate cancer. Despite its efficacy, resistance to olaparib remains a significant challenge. Understanding the molecular mechanisms underpinning this resistance is crucial for developing more effective treatment strategies. This study focuses on elucidating the role of mitochondrial alterations and the PTEN-induced kinase 1 (PINK1) gene in conferring olaparib resistance in castration-resistant prostate cancer cells. We investigated the transcriptomic and functional differences in mitochondrial activity between olaparib-resistant (2B-OlapR, LN-OlapR) and treatment-na prostate cancer cells (C4-2B, LNCaP) in both castration-sensitive and -resistant settings. Through RNA sequencing and gene set enrichment analysis, we identified significant enrichment of mitochondrial activity– and oxidative phosphorylation–related gene sets in olaparib-resistant derived cell lines. Resistant lines exhibited enhanced mitochondrial functionality, including increased basal and maximal respiration rates, as well as elevated ATP production and spare respiratory capacity, compared with parental cells. Subsequent investigations revealed a substantial increase in mitochondrial mass and electron transport chain complex I activity in  \nolaparib-resistant cells. Furthermore, overexpression of the PINK1 gene was observed in resistant cells, which was correlated with resistance toolaparib and poor clinical outcomes in patients with prostate cancer. Inhibition of PINK1 expression significantly reduced mitochondrial function and mass, impaired cell growth, and decreased resistance toolaparib. These findings suggest that PINK1 plays a crucial role in modulating mitochondrial dynamics that confer therapeutic resistance, highlighting its potential as a therapeutic target for overcoming olaparib resistance in prostate cancer.  \nSignificance: Olaparib, a PARP inhibitor, is effective against various  \ncancers, including prostate cancer. However, resistance to olaparib poses a significant challenge. This study uncovers that mitochondrial alterations and PINK1 gene overexpression contribute to this resistance in prostate cancer cells. Enhanced mitochondrial functionality and increased PINK1 expression in olaparib-resistant cells underscore the importance of targeting mitochondrial dynamics and PINK1 to develop more effective treatments for overcoming olaparib resistance in prostate cancer.  \nIntroduction  \nAs the most common organ-specific cancer diagnosis for men, prostate cancer is highly prevalent ( 1) . Initial therapies utilized for treatment which work to reduce systemic androgens such as castration- or androgen production–targeting therapeutics prove to be highly effective initially; however, in as little as just 5 years, almost 20% of patients experience castration-resistant prostate cancer (CRPC; refs. 2–4) . Discovery and  \n1Department of Urologic Surgery, University of California Davis, Davis, California. 2Division of Hematology and Oncology, University of California Davis, Davis, California. 3Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California. 4UC Davis Comprehensive Cancer Center, University of California Davis, Davis, California. 5VA Northern California Health Care System, Sacramento, California.  \nCorresponding Author: Allen C. Gao, University of California Davis, 4645 2nd  \nAvenue, Sacramento, CA 95817. E-mail: [acgao@ucdavis.edu](acgao@ucdavis.edu)  \n[","cbCaimP6lh1dvm9l","https://ap.wps.com/l/cbCaimP6lh1dvm9l","pdf",4540421,"English","# Abstract\n# Significance\n# Introduction","[{\"question\":\"What is the main biological focus of this study?\",\"answer\":\"The study focuses on how mitochondrial alterations and the PINK1 gene contribute to olaparib resistance in castration-resistant prostate cancer cells.\"},{\"question\":\"How was mitochondrial activity assessed in olaparib-resistant versus treatment-naive cells?\",\"answer\":\"It used transcriptomic comparisons with RNA sequencing and gene set enrichment analysis, followed by functional measurements of respiration, ATP production, and related mitochondrial parameters.\"},{\"question\":\"What effect does inhibiting PINK1 have on resistant prostate cancer cells?\",\"answer\":\"Inhibiting PINK1 expression reduces mitochondrial function and mass, impairs cell growth, and decreases olaparib resistance.\"}]","PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells | PDF",1790017522,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/164e1dfb08bfdeaef3fd760fa77a56b8.webp",983,1263,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8df0b2b8960adc25540597883c13405c.webp",982,1262,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6cc545c3825686bd2120b72ce3d6757.webp",981,1261,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b103decb41566edddebcbca4cbcc5b3.webp",980,1259]